Evaluation of TERT promoter mutations in tumor biopsies and urine sediment of Moroccan bladder cancer patients-Reference-Cited by-同舟云学术

Evaluation of TERT promoter mutations in tumor biopsies and urine sediment of Moroccan bladder cancer patients

Published:2022-01-31 Issue:1 Volume:30 Page:1-7
ISSN:1344-6835
Container-title:Annals of Cancer Research and Therapy
language:en
Short-container-title:Ann. Cancer Res. Therap.

Author:

Hafidi Alaoui Chaimae¹,El Ahanidi Hajar¹,El Azzouzi Meryem¹,Filali-Maltouf Abdelkarim²,Chaoui Imane¹,Bensaid Mounia³,Benbacer Laila¹,Tetou Mohammed³,Hassan Ilias³,Oukabli Mohamed⁴,Ameur Ahmed⁴,Al Bouzidi Abderrahmane⁴,Attaleb Mohammed¹,El Mzibri Mohammed¹

Affiliation:

1. Biology and Medical Research Unit, CNESTEN

2. Microbiology and Molecular Biology Laboratory, Faculty of Sciences, Mohammed V University in Rabat

3. Mohammed V Military Hospital

4. Faculty of Medicine and Pharmacy of Rabat. Mohammed V University in Rabat

Publisher

The Japanese Society of Strategies for Cancer Research and Therapy

Subject

Pharmacology (medical),Cancer Research,Oncology

Link

https://www.jstage.jst.go.jp/article/acrt/30/1/30_1/_pdf

Reference29 articles.

1. 1) Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J Clin. 2021;71:209-49. doi: 10.3322/caac.21660

2. 2) Benider A, Bendahhou k. Registre des cancers de la région du grand Casablanca 2008-2012. Ed 2016. 2016.

3. 3) Siddiqui MR, Grant C, Sanford T, et al. Current clinical trials in non-muscle-invasive bladder cancer. Urol Oncol. 2017;35:516-27.

4. 4) Jichlinski P, Leisinger H-J. Fluorescence cystoscopy in the management of bladder cancer: a help for the urologist! Urol Int. 2005;74:97-101.

5. 5) Yafi FA, Brimo F, Steinberg J, et al. Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer. Urol Oncol. 2015;33:66.e25-31.